(S)-cEt / Nucleoside Intermediates
DMT-protected (S)-cEt-A free-hydroxyl precursor
Quick view. A DMT-protected, N6-benzoyl (S)-cEt adenine nucleoside precursor with a free hydroxyl group, identified by CAS 1197033-18-3. CAS 1197033-18-3. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Priority |
| Reviewed supporting program count | 2 |
| Representative chemistry-platform program | opemalirsen |
| Highest development phase | Phase II |
| CAS status | Published registry number |
Product profile
DMT-protected (S)-cEt-A free-hydroxyl precursor is classified as (s)-cet / nucleoside intermediates (Formula C40H37N5O7; molecular weight 699.70).
DMT-protected (S)-cEt-A free-hydroxyl precursor is associated with adenine-containing building blocks or substrates for A-position incorporation and analytical comparison.
For DMT-protected (S)-cEt-A free-hydroxyl precursor, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- N-[9-[(1R,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]purin-6-yl]benzamide
Useful catalog search terms
- 1197033-18-3
- CDFUACRUGQPKNI-YUJUXCJOSA-N
Physicochemical data
| IUPAC name | N-[9-[(1R,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]purin-6-yl]benzamide |
|---|---|
| InChIKey | CDFUACRUGQPKNI-YUJUXCJOSA-N |
| SMILES | C[C@H]1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=NC4=C(N=CN=C43)NC(=O)C5=CC=CC=C5)O)COC(C6=CC=CC=C6)(C7=CC=C(C=C7)OC)C8=CC=C(C=C8)OC |
| PubChem CID | 45139474 |
| InChI | InChI=1S/C40H37N5O7/c1-25-39(22-50-40(27-12-8-5-9-13-27,28-14-18-30(48-2)19-15-28)29-16-20-31(49-3)21-17-29)34(46)33(51-25)38(52-39)45-24-43-32-35(41-23-42-36(32)45)44-37(47)26-10-6-4-7-11-26/h4-21,23-25,33-34,38,46H,22H2,1-3H3,(H,41,42,44,47)/t25-,33+,34-,38+,39-/m0/s1 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor
Intermediates · CAS: 1197033-21-8
OR-INTE-0113DMT-protected (S)-cEt-5-Me-C free-hydroxyl precursor
Intermediates · CAS: 1197033-15-0
OR-INTE-0115DMT-protected (S)-cEt-G free-hydroxyl precursor
Intermediates · CAS: 945628-65-9
OR-LP-0041Maleimide NHS Ester (SMCC)
Intermediates · CAS: 64987-85-5
OR-LP-00633'-Cholesteryl-TEG CPG
Intermediates · CAS: N/A
OR-INTE-01097'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine
Intermediates · CAS: N/A
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not an OROGO lot specification or product-performance claim.